Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection

Locked nucleic acid as a novel class of therapeutic agents

(2010) Rakesh N. Veedu et al.   RNA Biology

Transcriptional effects of transfection: the potential for misinterpretation of gene expression data generated from transiently transfected cells

(2009) Linda B. Jacobsen et al.   BIOTECHNIQUES

What have RNAi screens taught us about viral–host interactions?

(2009) Sara Cherry   CURRENT OPINION IN MICROBIOLOGY

The promises and pitfalls of RNA-interference-based therapeutics

(2009) Daniela Castanotto et al.   NATURE

Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents

(2009) C. A. Stein et al.   NUCLEIC ACIDS RESEARCH

SPC3042: a proapoptotic survivin inhibitor

(2008) J. B. Hansen et al.   MOLECULAR CANCER THERAPEUTICS

A RNA antagonist of hypoxia-inducible factor-1 , EZN-2968, inhibits tumor cell growth

(2008) L. M. Greenberger et al.   MOLECULAR CANCER THERAPEUTICS

c-myc Antisense Oligonucleotides Sensitize Human Colorectal Cancer Cells to Chemotherapeutic Drugs

(2008) Mohamed-Salah I. Abaza et al.   TUMOR BIOLOGY